The QualityStocks Daily Stock List
- First Acceptance Corporation (FACO)
- GenTech Holdings, Inc. (GTEH)
- Major Drilling Group International, Inc. (MJDLF)
- Nephros, Inc. (NEPH)
- Oil Search Limited (OISHF)
- Valeritas Holdings, Inc. (VLRX)
- Energy and Water Development Corp. (EAWD)
- Comepay, Inc. (CMPY)
- FogChain Corp. (FOGCF)
- American Green, Inc. (ERBB)
- Micromem Technologies, Inc. (MMTIF)
- Medibio Limited (MDBIF)
- CurAegis Technologies, Inc. (CRGS)
- Elcora Advanced Materials Corp. (ECORF)
First Acceptance Corporation (FACO)
Zacks, OTC Markets, Simply Wall St, Wallet Investor, Stockhouse, Stockwatch, Glassdoor, TipRanks, MacroTends, Research Pool, Investing.com, InvestorsHub, Insider Tracking, GlobeNewswire, Stockopedia, and Digital Journal reported previously on First Acceptance Corporation (FACO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
First Acceptance Corporation, via its subsidiaries, operates as a retailer, servicer, and underwriter of non-standard personal automobile insurance and other ancillary products in the USA. The Company’s insurance operations produce revenue from selling these products in 17 States. At March 31, 2019, First Acceptance leased and operated 348 retail locations and a call center staffed with employee-agents. Formed in 1969, First Acceptance has its head office in Nashville, Tennessee. The Company’s shares trade on the OTC Markets Group’s OTCQX.
First Acceptance presently conducts its insurance servicing and underwriting operations in 15 States and operates only as an insurance agency in two States. In addition, the Company is licensed as an insurance company in 11 States where it does not conduct any business.
Products that First Acceptance offers include Auto Insurance, Motorcycle Insurance, Roadside Assistance, Renters Insurance and Homeowners Insurance. Products offered also include Commercial Insurance, Pet Insurance, Life Insurance, as well as Travel Insurance.
First Acceptance’s employee-agents primarily sell non-standard personal automobile insurance products underwritten by First Acceptance and through third-party carriers for which First Acceptance receives a commission. Furthermore, the Company offers a variety of additional commissionable products. Moreover, in most States, its employee-agents sell an insurance product providing personal property and liability coverage for renters that is underwritten by First Acceptance.
This month, First Acceptance Corporation reported its financial results for the three and nine months ended September 30, 2019. Income before Income Taxes, for the three months ended September 30, 2019 was $6.2 million, versus $6.5 million for the three months ended September 30, 2018. Net Income for the three months ended September 30, 2019 was $4.8 million, versus $5.2 million for the three months ended September 30, 2018.
Income before Income Taxes, for the nine months ended September 30, 2019 was $22.3 million, versus $20.0 million for the nine months ended September 30, 2018. Net Income for the nine months ended September 30, 2019 was $17.4 million, versus $15.4 million for the nine months ended September 30, 2018.
First Acceptance Corporation (FACO), closed Monday's trading session at $0.75, even for the day, on 40,340 volume with 14 trades. The average volume for the last 3 months is 18,562 and the stock's 52-week low/high is $0.569999992/$1.50.
GenTech Holdings, Inc. (GTEH)
Stock of the Week, TipRanks, OTC Markets, Street Insider, Nasdaq, Stockhouse, Investing.com, Market Screener, Dividend Investor, Investors Hangout, Dividend.com, Wallet Investor, Morningstar, Otc.watch, GuruFocus, TradingView, Stockwatch, GlobeNewswire and Stockopedia reported earlier on GenTech Holdings, Inc. (GTEH), and today we report on the Company, here at the QualityStocks Daily Newsletter.
GenTech Holdings, Inc. is an emerging leader in the high-end CBD (cannabidiol) food and drinks marketplace. It is creating a national chain of Hemp Centric Coffee Shop Retail Spaces. This is where customers can relax, drink CBD infused Teas and Coffees, try various own-brand products and experience holistic education and classes. GenTech Holdings has its corporate headquarters in New York, New York. The company lists on the OTC Markets.
GenTech will be offering alternatives to standard coffees, teas and chocolate. Additionally, the Company is building an extensive outreach program working with medical practitioners throughout the nation in their own locations to educate their patients and increase awareness of the benefits of THC (Tetrahydrocannabinol) free CBD Products. All of this is offered under the brand 'The Healthy Leaf'.
Last month, GenTech Holdings announced that it engaged a specialist CBD infusion company from Southern California. They are a premium CBD and high-quality food infuser. They will handle grinding and CBD-infusion for GenTech’s premium imported Brazilian coffee beans. GenTech anticipated that it would have an initial shipment ready for marketing and distribution via its Healthy Leaf ecommerce platform within 30 days (from date of press release – October 23, 2019).
The order represents a supply chain and workflow test. It is expected to produce GenTech’s initial 1,300 bags of CBD infused ground coffee to be marketed and sold under the Healthy Leaf brand. This order will be followed by an additional 10,000 kg of fresh imported beans. This will represent enough raw input to produce roughly 45,000 bags of CBD infused Healthy Leaf ground coffee.
The overall market for CBD-based products is set for 900 percent growth this year (according to Brightfield Group research), and millennials are now ascending to be the fastest growing consumers of CBD and Coffee simultaneously (according to NCA data). Thus, GenTech anticipates a very robust market context for this product line, both in its initial ecommerce launch and as an in-store product following the Grand Opening of The Healthy Leaf CBD-Infusion café in Q1 of 2020.
GenTech Holdings, Inc. (GTEH), closed Monday's trading session at $0.0023, off by 11.5385%, on 1,194,978 volume with 42 trades. The average volume for the last 3 months is 2,258,594 and the stock's 52-week low/high is $0.002/$0.369500011.
Major Drilling Group International, Inc. (MJDLF)
24hgold, Street Insider, Nasdaq, Macroaxis, Market Screener, Invest Tribune, Capital Cube, Wallmine, 4-Traders, Wallet Investor, YCharts, GuruFocus, Northern Miner, Dividend Investor, Nasdaq, Stockhouse, MarketWatch, Morningstar, Seeking Alpha and MarketBeat reported beforehand on Major Drilling Group International, Inc. (MJDLF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
Major Drilling Group International, Inc. provides contract drilling services for mining and mineral exploration companies in the United States, Canada, Mexico, South America, Asia, Africa, and Europe. As of April 30, 2019, it had a fleet of approximately 601 drilling rigs. The Company is one of the world’s largest drilling services companies primarily serving the mining industry. Established in 1980, Major Drilling Group is headquartered in Moncton, New Brunswick.
The Company is registered in more than 20 countries on 6 continents. Its Senior Management has greater than 1,000 years of combined experience. Regarding the emergence of “Specialized Drilling” Major Drilling Group’s business premise is that the new deposits over the next 20 years will be in areas difficult to access and that specialized drilling will be a greater part of the market.
Major Drilling Group offers a suite of drilling services. These include surface and underground coring, directional, reverse circulation, sonic, geotechnical, environmental, water-well, coal-bed methane, shallow gas, underground percussive/longhole drilling, surface drill and blast, and various mine services.
Major Drilling Group offers services including mineral exploration, directional drilling, definition or infield drilling, mine development, dewatering, grade control, and percussive drilling for a producing mine. Its environmental and sonic group can help sample tailings piles, monitor tailings dams, install grout curtains, as well as install ground water sampling wells.
At the beginning of November, Major Drilling Group International announced the closing of the earlier announced acquisition of all of the issued and outstanding shares of privately-held Norex Drilling Limited. Norex is a family-owned drilling company and a foremost exploration drilling contractor headquartered in Timmins, Ontario.
Major Drilling Group International will release its Q2 results, ended October 31, 2019, on Wednesday, December 4, 2019 after the markets have closed. Mr. Denis Larocque, President & Chief Executive Officer, and Mr. Ian Ross, Chief Financial Officer, invite those interested to participate in a webcast/conference call on Thursday, December 5, 2019 at 9:00 a.m. Eastern to discuss the Company’s Q2 results for Fiscal 2020.
Major Drilling Group International, Inc. (MJDLF), closed Monday's trading session at $3.96, off by 1.9802%, on 4,000 volume with 16 trades. The average volume for the last 3 months is 5,856 and the stock's 52-week low/high is $2.92000007/$5.03499984.
Nephros, Inc. (NEPH)
Zacks, StreetWise Reports, Investing.com, GlobeNewswire, Stockwatch, Stockhouse, Simply Wall St, Proactive Investors, Market Screener, Wallet Investor, Last10k, OTC Markets, MarketWatch, Nasdaq, Stockopedia, and Morningstar reported beforehand on Nephros, Inc. (NEPH), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Nephros, Inc. is a commercial-stage company that develops and sells high performance water purification products to the medical device and commercial markets. Nephros filters, including AETHER™ brand filters, improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. Nephros and AETHER™ products are used in the health care, food service, hospitality, and convenience store markets. Nephros is based in South Orange, New Jersey. The Company’s shares trade on the NasdaqGS.
Nephros’ ultrafilters are used in hospitals and medical clinics for added protection in retaining bacteria (e.g., Legionella, Pseudomonas) and viruses from water. These ultrafilters provide barriers that help in improving infection control in showers, sinks, and ice machines.
In addition, Nephros ultrafilters are used by dialysis centers for assisting in the added removal of endotoxins and other biological contaminants from the water and bicarbonate concentrate supplied to hemodialysis machines and patients. Nephros offers Infection Control Ultrafilters, Dialysis Ultrafilters, as well as Commercial Ultrafilters.
Earlier this month, Nephros announced financial results for the three months ended September 30, 2019. In the Water Filtration Business Segment Product Revenue was $3.1 million. This is up 85 percent versus $1.6 million in 2018. Net Loss was $347,000, versus $246,000 in 2018. Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) was $182,000, versus ($18,000) in 2018.
Regarding Consolidated highlights, Net revenue was $3.1 million. This is up 80 percent versus $1.7 million in 2018. Net Loss was $744,000, versus $550,000 in 2018. Adjusted EBITDA was ($209,000), versus ($322,000) in 2018.
Daron Evans, President and Chief Executive Office of Nephros, said, “Our momentum continued in Q3, our 13th consecutive quarter of year-over-year revenue growth averaging over 65 percent. Growth came from both an expansion of our base business as well as from increased outbreak support. We are pleased with the development progress of our waterborne pathogen detection system and expect to be in the field helping customers before the end of this year. We also reaffirm our recently increased full-year revenue guidance of $9.5 to $10 million.”
Nephros, Inc. (NEPH), closed Monday's trading session at $8.20, up 2.50%, on 12,055 volume with 78 trades. The average volume for the last 3 months is 18,493 and the stock's 52-week low/high is $3.69000005/$11.3500003.
Oil Search Limited (OISHF)
Stock Target Advisor, TipRanks, OTC Markets, TeleTrader, Stockscores, YCharts, Capital Cube, 24hgold, Dividend Investor, Market Screener, Morningstar, Seeking Alpha, GuruFocus, Stockhouse, 4-Traders, Wallet Investor, MarketWatch, and Nasdaq reported earlier on Oil Search Limited (OISHF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Oil Search Limited is Papua New Guineas’ (PNG) largest company and investor. It operates all the nation’s producing oil fields and holds a wide-ranging appraisal and exploration portfolio. The Company’s 29 percent interest in the ExxonMobil-operated PNG LNG Project has transformed Oil Search into a regionally significant oil and gas producer.
The Company also holds a material interest in the Elk-Antelope and P’nyang gas fields that are expected to underpin the proposed construction of three additional LNG trains. In addition, Oil Search is undertaking a range of activities to support more LNG expansion in PNG. Oil Search Limited is based in Port Moresby, PNG. The Company lists on the OTC Markets.
The PNG LNG Project is a world-class liquefied natural gas development. It came on-stream in 2014. The PNG LNG Project has consistently operated above its nameplate capacity of 6.9 million tonne per annum (MTPA). In the second half of 2018, Gross LNG production reached an annualized rate of 8.8 million tonnes per annum (MTPA).
Project gas is sourced from seven fields. These are the Hides, Angore and Juha gas fields and from associated gas in the Company-operated Kutubu, Agogo, Moran and Gobe Main oil fields, which provides about 20 percent of PNG LNG Project gas. Furthermore, Gas is purchased on a third party basis from the SE Gobe field.
In February of 2018, Oil Search completed the purchase of world class oil assets in Alaska’s North Slope. This acquisition is consistent with its stated strategy to pursue material, high-returning, worldwide liquids opportunities to complement its high-quality PNG gas assets. The assets acquired include the Nanushuk field in the Pikka Unit, satellite fields within the Nanushuk and Alpine Fairways, and the Horseshoe discovery. Moreover, assets acquired include a portfolio of highly prospective exploration acreage.
Pertaining to Crude Marketing, Kutubu Blend comprises crude oil from Oil Search’s operated oil fields and liquids from the PNG LNG Project. Oil production is sourced from the Kutubu, Moran and Gobe fields in the Southern Highlands of Papua New Guinea.
PNG LNG liquids are separated from the gas stream at the Hides Gas Conditioning Plant. They are then transported to the Oil Search-operated Kutubu Central Processing Facility. There, they are blended with the crude oil and piped to the Kumul Marine Terminal, positioned offshore in the Gulf of Papua, for export. The combined production averages approximately 55,000 bopd.
This month, Oil Search announced it launched a Science, Technology, Engineering and Mathematics (STEM) Scholarship Programme for Papua New Guineans attending technical schools and universities. This continues the Company’s long history of providing young people with opportunities to jumpstart their careers. The scholarships, worth K5.7m, are open to all Papua New Guineans, with priority given to candidates from Oil Search’s project impact area provinces based on merit and includes support to secondary schools.
Oil Search Limited (OISHF), closed Monday's trading session at $4.94, even for the day, on 1,000 volume. The average volume for the last 3 months is 171 and the stock's 52-week low/high is $4.23000001/$6.09000015.
Valeritas Holdings, Inc. (VLRX)
Zacks, StocksBeat, Nasdaq Trader, Proactive Investors, Infront Analytics, Investors Observer, AI Stock Finder, Alpha Stock News, StockTwits, Stocks Equity, Stockwatch, Stockhouse, and MacroTrends reported previously on Valeritas Holdings, Inc. (VLRX), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Valeritas Holdings, Inc. is a medical technology company and the maker of the V-Go® Wearable Insulin Delivery device that utilizes its proprietary h-Patch™ technology. The Company’s focus is on improving health and simplifying life for people with diabetes through developing and commercializing unique technologies. It sells V-Go® to third-party wholesalers and medical supply distributors. A commercial-stage medical technology enterprise, Valeritas Holdings is based in Bridgewater, New Jersey. The Company operates its research and development (R&D) functions in Marlborough, Massachusetts. Valeritas Holdings lists on the NasdaqCM.
The V-Go® Wearable Insulin Delivery device is the Company’s flagship product. V-Go® is a simple, affordable, all-in-one basal-bolus insulin delivery option for patients with Type 2 Diabetes. It is worn like a patch. It can eliminate the need for taking numerous daily shots. V-Go administers a continuous pre-set basal rate of insulin over 24 hours. Furthermore, it provides discreet on-demand bolus dosing at mealtimes.
V-Go is the only basal-bolus insulin delivery device on the contemporary market purposely designed keeping in mind the needs of Type 2 Diabetes patients. V-Go is cleared for use in the United States and the European Union. It is commercially available in the United States.
Valeritas is developing two next generation single-use disposable V-Go devices - V-Go PreFill™ and V-Go SIM™. V-Go PreFill™ will enable Valeritas to sell V-Go along with the insulin in one commercial product. It will feature a prefilled insulin cartridge that the patient can snap into the V-Go device eliminating the insulin-filling process.
V-Go SIM™ will feature one-way communication to smart devices via RF/Bluetooth technology. V-Go Link™ will provide real-time tracking information of basal and bolus dosing use.
Valeritas’ h-Patch™ is a drug delivery technology. It can facilitate the simple and effective subcutaneous delivery of injectable medicines to patients across a broad array of therapeutic areas. Valeritas’ V-Go is the first FDA-approved (Food and Drug Administration) product that utilizes the h-Patch™ technology.
Earlier this month, Valeritas announced additional data from the VERDICT study presented at the 19th Annual Diabetes Technology Meeting held in Bethesda, Maryland. This data demonstrated positive clinical outcomes for patients with Type 2 Diabetes who switched insulin therapy to V-Go from a basal-only, basal-bolus, or premix insulin regimen.
Mr. John Timberlake, President and Chief Executive Officer of Valeritas Holdings, said, “We are excited to share these positive clinical data from the VERDICT study. We believe these results further demonstrate that, regardless of baseline insulin dose, the use of V-Go can offer patients with Type 2 Diabetes significant clinical benefit when switching from other insulin regimens.”
Valeritas Holdings, Inc. (VLRX), closed Monday's trading session at $1.64, up 9.3333%, on 290,319 volume with 826 trades. The average volume for the last 3 months is 246,639 and the stock's 52-week low/high is $1.10000002/$11.394.
Energy and Water Development Corp. (EAWD)
PR Newswire, Nasdaq, Stockopedia, Seeking Alpha, GlobeNewswire and Market Screener reported previously on Energy and Water Development Corp. (EAWD), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
Energy and Water Development Corp. is a green-tech engineering solutions company listed on the OTC Markets. Its emphasis is on delivering water and energy to extreme environments. The Company builds water and energy systems out of already-existing, proven technologies, using its technical knowledge to customize solutions to their clients’ needs. Energy and Water Development is based in Miami, Florida.
Last month, Eurosport Active World Corporation (EAWD) announced its name change to Energy and Water Development Corp. This is to better reflect its aforementioned business strategy of operating a green-technology engineering solutions company centered on delivering water and energy to extreme environments.
Mr. Ralph Hofmeier, Chief Executive Officer, said, “The name change is the first in a series of steps we are taking to align our marketing and branding strategies to more accurately reflect our business.”
Energy and Water Development offers design, construction, maintenance, and specialty consulting services to private companies, government entities, and non-government organizations (NGOs). The Company has acquired the relevant licenses that give it the right to sell and produce the associated technologies while ensuring, via its partnership with Swiss Water Tech R&D, the provision of related services. These services include Research & Development, technical maintenance; education; and training.
Energy and Water Development has turnkey technologies from Germany and other European nations. It also has turnkey solutions with considerable potential for growth globally. Moreover, the Company has clean, energy-and-cost saving solutions that are easy to install; mobile; self-contained; and built to last. Furthermore, it has Carbon Tax-Free Projects. Energy and Water Development’s advantage is having worldwide distributor licenses, patents, and the advantage of German and other European technologies.
In April 2019, the Company announced that an agreement was signed to lease its Atmospheric Water Generation technological solutions by way of lease programs in South Africa. It announced in March 2019 the launching of The Blue Aqua Mission™ System. This is a state-of-the-art German engineered Atmosphere Water Generation (AWG) technology that is totally powered by renewable energy. This system consists of a suite of intelligent software solutions for real-time optimization of process performance, and operates through its own inventive self-powered system.
Energy and Water Development Corp. (EAWD), closed Monday's trading session at $0.25, up 66.6667%, on 14,000 volume with 3 trades. The average volume for the last 3 months is 32,539 and the stock's 52-week low/high is $0.100000001/$3.75.
Comepay, Inc. (CMPY)
InvestorsHub, Business Insider, and Nasdaq reported on Comepay, Inc. (CMPY), and we also report on the Company, here at the QualityStocks Daily Newsletter.
Comepay, Inc. provides Internet acquiring and support services. In addition, the Company engages in facilitating instant payments and internet based payment transactions via kiosks, mobile interfaces, and Web-based applications. The Comepay group of companies includes Comepay, RP Systems, M-NN LLC, and Chek-Online. Comepay has its corporate headquarters in Vaughan, Ontario.
The Company also leases and sells cash registers and point of sale (POS) systems. This includes its recently developed proprietary multifunctional smart POS fiscal cash register system. Comepay processes more than 4.7 million customer payments monthly. At present, the Company has greater than 12,700 kiosks throughout Russia.
The above-mentioned companies are now concentrating their planned business expansion on the smart POS fiscal cash register system "Cassatka". This is to help businesses comply with Russian taxation legislation, 54-FZ, that required 1.2 million businesses in fiscal 2018, and a further 1.4 million businesses in fiscal 2019 to install new, federally compliant on-line cash registers.
The Cassatka is Comepay's multifunctional smart POS online fiscal cash register. Cassatka can process payments and meet fiscal data storage requirements for participating businesses. Cassatka is a convenient and cost competitive solution for businesses to meet the new federal taxation requirements in Russia.
As the companies expand their business model, Comepay expects to offer blockchain acquiring services and to accept payments in numerous crypto currencies on the Cassatka. The Comepay group of companies currently earn revenue from an array of channels. These include fee-based commissions on payment processing for cash and debit card payments, software licensing, kiosk placement fees and other rental fees for cash registers and associated equipment.
This past February, Comepay announced that its wholly-owned subsidiary, Chek-Online LLC, again added more functionality to its smart terminals through integrating merchant acquiring services from two large banks in Russia for its versatile handheld Cassatka-Mini terminal. Chek-Online is a foremost manufacturer of fiscal cash registers in Russia, and the developer of the family of Cassatka smart terminals.
Chek-Online plans to expand to several more partner banks for trade acquiring for its Cassatka-Mini Smart terminal. Nonetheless, the integration process has already been launched with two large banks based in Russia, VTB Bank and Otkritie FC Bank.
Recently, Comepay announced that Chek-Online concluded an agreement with the National Payment Card System (NSPK) for the use of contactless payment system “Mir” for the Cassatka Mini series of smart terminals. NSPK is the operator of the Russian national contactless payment system “Mir”. NSPK recently concluded an agreement with Chek-Online for the supply of materials required to develop customized solutions for the Cassatka Mini mobile smart terminal. This include contactless payments.
Comepay, Inc. (CMPY), closed Monday's trading session at $0.29615, up 43.7621%, on 1,869 volume with 7 trades. The average volume for the last 3 months is 2,470 and the stock's 52-week low/high is $0.205300003/$5.25.
FogChain Corp. (FOGCF)
StockReads, Stock Orange, Stockwatch, Bullish Guru, Penny Stock Hub, Press Reader, Investors Hangout, 4-Traders, OTC Markets, InvestorsHub, MarketWatch, Barchart, Insider Financial, Stockhouse, TradingView, Market Screener, and Wallet Investor reported previously on FogChain Corp. (FOGCF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
FogChain Corp. is a completely integrated, end-to-end software development life cycle (SDLC) and quality assurance solutions provider. The Company’s set of services and technology provides application development at scale with more speed, efficiency and at a lesser cost. FogChain's Build-Once Deploy-Everywhere software architecture provides developers with a set of tools and resources that bridges devices, operating systems, and the ability to build and launch new applications in a unified environment. OTCQB-listed, FogChain is based in Vancouver, British Columbia.
FogChain has acquired RadJav, which provides developers with fast application development tools and resources for the creation of mobile and web apps, smart contracts, and dApps. These are to be used across all major operating systems and devices on a unified platform. In addition, FogChain also acquired Quilmont - a growing and profitable software development solutions provider specializing in automated testing, Continuous Integration and Deployment (CI/CD), mobile and website development, and software quality assurance.
Fundamentally, FogChain provides a next generation platform. This platform seamlessly integrates application development and deployment that leverages a high-performance Fog (or Edge) based computing network to drive scale and connects with the unique and ground-up built RadJav Blockchain. FogChain is introducing the next generation of decentralized compute to the world of software development and application lifecycle management.
RadJav has completed the integration of Visual Studio Code (VS Code) into its platform. The RadJav platform provides fast application development tools and resources to build and launch applications across all devices, from PCs to tablets and smartphones, and also operating systems such as Linux, Windows, Mac OSX, and Apple's iOS - all using the same code.
Fog Computing utilizes decentralized and distributed computing resources and application services that are closer to the Edge, or actual point of use. Fog Computing integrates with the most current technologies. These include IoT (Internet of Things), Blockchain, 3D & Virtual Reality engines, and analytics tools. It can leverage underused resources, reducing costs.
FogChain announced this past November that it commercialized and launched its Automated Application Testing Platform, Test Case Manager (TCM), an enterprise grade software application testing solution. TCM is a patented automated testing product. It enables organizations to accomplish substantial cost savings and improved time to market through automating their test cases.
FogChain also reached an agreement to acquire AppMark's application monitoring and benchmarking platform (AppMon) and other related assets for the issuance of one million shares and $40,000 USD. AppMark (Redwood City, California) is a SaaS solutions provider. It specializes in synthetic performance monitoring of enterprise mobile, web, as well as desktop applications.
Recently, FogChain announced it completed work on an initial release of Trident. This is a unified cross-platform application development, testing and monitoring services platform. Trident's Build-Once-Deploy-Everywhere software architecture provides developers with a group of tools to build, test, and monitor new applications using a single code-base while being natively deployed across desktop, tablet, and mobile devices.
Trident will feature the ability to deploy virtual testing labs across an array of web browsers and all major operating systems. The containerized approach permits companies to scale their development, testing, and monitoring processes with minimal effort and considerable cost savings.
FogChain Corp. (FOGCF), closed Monday's trading session at $0.0162, up 62.00%, on 1,000 volume with 1 trade. The stock's 52-week low/high is $0.000099999/$0.136000007.
American Green, Inc. (ERBB)
Insider Financial, Best Medical Marijuana Stocks, Morningstar, YCharts, Daily Marijuana Observer, InvestorsHub, Wall Street Alerts, Guru Focus, MarketWatch, Stockhouse, otc.watch, Wallet Investor, Seeking Alpha, Market Screener, Awesome Penny Stocks, New Cannabis Ventures, Barchart, and Marijuana Stocks reported earlier on American Green, Inc. (ERBB), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.
American Green, Inc. operates the U.S. as a technology company in the medical cannabis industry. It became one of the first publicly traded technology companies in the medical cannabis industry globally, beginning in 2009, with the introduction of the ZaZZZ machine for automated, age-verifying dispensing of cannabis-based medicines. American Green’s dedication is to the developing cannabis market. The Company is based in Phoenix, Arizona.
American Green has its AGM verified vending system. The Company enables businesses to securely vend age-restricted products. This includes cannabis, beer, tobacco, pharmaceuticals, and more.
American Green has a state-of-the-art cultivation facility in Phoenix. Furthermore, it is involved with the sale or creation of a number of apps supporting cannabis and small businesses alike. This includes the Blaze Now dispensary locator that can be found in the Apple and Android app stores, as well as the Company’s Xpress app.
In September 2017, American Green purchased the desert town of Nipton, California. In October, it announced that it completed Phase One of its integration into Nipton. The Company’s stated goal for the town's future is for it to become the first energy-independent cannabis-friendly town in America. The new focus for the Town of Nipton is as a host location for cannabis tourism and a center for art and nature educational workshops.
American Green entered into a Joint Venture (JV) to form a CBD processing plant in Nipton with MediaTechnics Corporation (MEDT). With this JV, MEDT is to specify, procure, design, develop and install a state-of-the-art extraction facility in Nipton that can extract Cannabidiol (CBD) from Industrial Hemp.
American Green also completed its acquisition of Delta International Oil and Gas (DLTZ) through the sale of its Nipton assets. As a result, American Green gained control of Delta. Delta operates as a subsidiary of American Green. The expectation is that Delta International will invest heavily in Nipton and other American Green-run projects.
American Green announced in June 2018 that its state-of-the-art, 12,000 square foot medical cannabis grow facility opened in Phoenix. The facility commenced operations immediately. All products produced sell through American Green’s licensed grow partner, Natural Herbal Remedies.
American Green announced in 2018 that it entered into a Memorandum of Understanding (MOU) to create American Green Films, LLC. This is to produce commercial motion pictures, the first of which will use Nipton as its central location.
American Green announced in August of 2018 that its subsidiary, Delta International Oil & Gas, changed its name to CannAwake Corporation with the new stock symbol (CANX). American Green and CannAwake have completed the purchase of the solar power generating station in Nipton, California.
Recently, American Green announced that the cannabis grow operation it manages for its Licensee, Natural Herbal Remedies, was anticipated to reach full production in January. This 12,000 sq. ft. grow operation, on the west side of Phoenix, was years in the making because of numerous State and local licensing, permitting, and building modification issues. However, according to Mr. David Gwyther, American Green’s President, “It was worth the wait. The facility, which we call “Sweet Virginia,” is now turning out some of the best cannabis in the state of Arizona!”
American Green, Inc. (ERBB), closed Monday's trading session at $0.0288, up 39.1304%, on 6,095,070 volume with 321 trades. The average volume for the last 3 months is 626,349 and the stock's 52-week low/high is $0.004999999/$0.252499997.
Micromem Technologies, Inc. (MMTIF)
MarketWatch, Penny Stock Tweets, Infront Analytics, Equity Clock, InvestorsHub, SmallCapVoice, Dividend Investor, last10k, Xtremepicks, OurHotStockPicks, GuruFocus, Wallet Investor, Stockhouse, Morningstar, Stock Stars, Trading View, PennyStocks24, Capital Cube, Investors Hangout, and Pink Investing reported earlier on Micromem Technologies, Inc. (MMTIF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Micromem Technologies, Inc. is a leader in viable Sensor Technology and MRAM (Magnetoresistive Random Access Memory). At present, the Company is focused on magnetic sensor applications via its wholly-owned subsidiary, Micromem Applied Sensor Technologies, Inc. (MAST, Inc.). OTCQB-listed, Micromem Technologies is based in Toronto, Ontario. The MAST, Inc. subsidiary is based in New York, New York.
Micromem’s technologies and solutions include surface functionalization of magnetic nanoparticles; nanoparticle detection platforms to sub-ppb detection levels; customized integration of NEMS/MEMS sensor platforms; magnetic sensor solutions; and sensor-based analytical solution platforms. Technologies and solutions also include structural integrity sensors; wireless suib-surface power solutions; asset protection sensor platforms; and energy storage solutions.
Micromem Technologies designs, develops and provides sensors specific to industry needs. The MAST subsidiary centers on developing and marketing the delivery of inventive magnetic sensor applications in industries including Defense, Life Sciences, Automotive, Consumer, and Mining. MAST develops MEMS/NEMS solutions through combining disparate sensor modalities to create solutions for clients’ problems.
MAST works closely with its clients during development to ensure a smooth transfer to their production facility. MAST is not a product company.
Concerning Energy Storage Solutions, MAST, working together with an energy storage company and a top U.S. utility, is providing sensor technology and overall system and product integration management for the practical realization of a new energy storage system. This system will enable lower costs than building new power generating plants.
Pertaining to its Magnetic Nanoparticle Detection Platform, MAST, working with a leader in the oil industry, has developed an instrument that detects breakthrough water in production oil wells through magnetic and optical sensor techniques.
Recently, Micromem Technologies, via Micromem Applied Sensor Technologies, Inc. (MAST), announced an update on the status of the ATRA 171 project it has been developing over the last 5 years with its oil company partner, Chevron Corporation (NYSE: CVX). With this agreement, the continuing pilot project is proceeding through on site well evaluation. Also, the commercialization plans for this technology are progressing.
Micromem Technologies, Inc. (MMTIF), closed Monday's trading session at $0.0264, up 76.00%, on 3,241,990 volume with 48 trades. The average volume for the last 3 months is 1,341,562 and the stock's 52-week low/high is $0.010499999/$0.129999995.
Medibio Limited (MDBIF)
Awesome Penny Stocks, Wallet Investor, The Street, TradingView, Morningstar, Penny Stock Hub, Stockwatch, OTC Markets, Investing Online, Otc.Watch, Investors Hangout, Stockhouse, 4-Traders, and Global Banking and Finance reported earlier on Medibio Limited (MDBIF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
Medibio Limited is a digital health company with offices in Melbourne (Vic), and Minneapolis, Minnesota. It has developed an objective testing system to assist in the screening, diagnosis, and treatment effectiveness of depression, chronic stress, and other mental health disorders. The test uses patented (and patent pending) circadian heart rate variability and cloud based proprietary algorithms to deliver a quantifiable measure to assist in clinical diagnosis. Medibio lists on the OTC Markets’ OTCQB.
Medibio is on course to commercialize its platform technology called the Digital Mental Health Platform. The basis of this is on patented biomarkers from the autonomic nervous system. The Company’s technology will provide a Diagnosis Aid to help General Practioners (GPs) and mental health clinicians. Medibio’s technology provides the first objective measure of stress. It provides a series of user and corporate dashboards for assessment and wellness partner interventions.
Regarding biomarker based objective diagnosis, a panel of circadian, sleep, and automatic system biomarkers enables automated, repeatable, and objective characterization of the impact of mental illness on the physiologic state. Medibio’s Digital Mental Health Platform is a device agnostic platform. It can ingest data from many devices. It is highly scalable, low cost, as well as easy to integrate.
Medibio announced in October 2018 the release of ilumen™. This is its product and platform for corporate customers. ilumen™ is a corporate wellness product providing employers the ability to offer biometric analysis and objective, data-driven feedback along with a mental wellness assessment to their employees.
Recently, Medibio announced that it signed an exclusive agreement with AIAA to undertake a pilot program for the latest release of its corporate health program, ilumen™. AIAA is one of Australia’s leading life insurers. AIAA is part of the AIA Group, which is the largest independent publicly listed pan-Asian life insurance group. It has a presence in 18 markets around the Asia-Pacific region. AIAA will have access to ilumen™ over a six-month period for its Australia and New Zealand employees.
Medibio Limited (MDBIF), closed Monday's trading session at $0.00921, up 84.20%, on 15,000 volume with 1 trade. The average volume for the last 3 months is 61,647 and the stock's 52-week low/high is $0.0013/$0.035.
CurAegis Technologies, Inc. (CRGS)
Penny Stock Tweets, Dividend Investor, Insider Mole, Equity Clock, Market Screener, Morningstar, MarketWatch, 4-Traders, InvestorsHub, Stockwatch, Investor Place, Simply Wall St, Marketbeat, Capital Cube, YCharts, Stock Invest, Barchart, The Street, OTC Markets, Infront Analytics, Stockhouse, last10k, Wallet Investor, and TradingView reported earlier on CurAegis Technologies, Inc. (CRGS), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
CurAegis Technologies, Inc. develops and markets advanced technologies in the areas of power, safety, and wellness. The Company consists of two independent divisions. One is its CURA Division and the other is its Aegis Division. CurAegis is now concentrating on commercialization strategies in diverse technologies. These include the CURA system, which includes the myCadian™ watch that measures degradation of alertness and sleep attributes; the Z-Coach e-learning education and training tool, and the Aegis hydraulic pump. OTCQB-listed, CurAegis Technologies is based in Rochester, New York.
The CURA™ system and the myCadian™ watch enable the user and third parties to anticipate and prevent undesired or disastrous situations caused by the degradation of alertness. CurAegis completed its validation studies of the CURA System at the University of Colorado at Boulder and the University of Rochester Medical Center. The Company previously said that it can now state that it can predict a person’s fatigue level, at close to laboratory accuracy, in real-time.
The CURA System consists of hardware and software, which measures numerous metrics to establish that a person's ability to perform a task or job appears to be degrading. The CURA division is developing a proprietary technology and family of products designed to measure the reduction in a person’s alertness and to train persons on how to improve alertness levels. The CURA System gives a person accurate and relevant real-time information regarding their current and long-term sleep and fatigue health.
The Company’s Aegis hydraulic pump (Aegis Division) is an innovative hydraulic design. Its goal is to deliver better efficiencies in a package that is smaller and lighter than contemporary technologies. Moreover, in 2015, the Z-Coach e-learning tool was acquired by CurAegis Technologies. The Z-Coach® Wellness Program is a robust, proven and proprietary online sleep training and education solution to address sleep issues and improve wellness.
Recently, Mr. Richard A. Kaplan, Chief Executive Officer of CurAegis Technologies announced that Mr. Lance F. Drummond was appointed to the Company’s Board of Directors. At present, Mr. Drummond is a Board member of Federal Home Loan Mortgage Corporation (Freddie Mac). He has served on the Audit Committee and Nominations and Governance Committee since 2015. He is a Board member for United Community Bank, Inc. since 2018, where he serves on the Risk Committee, Nominating and Governance Committee and Compensation Committee.
CurAegis Technologies, Inc. (CRGS), closed Monday's trading session at $0.099, up 41.4286%, on 17,589 volume with 4 trades. The average volume for the last 3 months is 16,729 and the stock's 52-week low/high is $0.005599999/$0.300000011.
Elcora Advanced Materials Corp. (ECORF)
InvestorIntel reported previously on Elcora Advanced Materials Corp. (ECORF), and we report on the Company today, here at the QualityStocks Daily Newsletter.
Elcora Advanced Materials Corp. has been designed to become a vertically integrated (from mine to product) graphite & graphene company, which mines, processes, refines graphite, and produces the graphene and end user graphene applications. The Company has developed a unique low cost-effective process to make high quality graphite and graphene that are commercially scalable. Elcora Advanced Materials is based in Bedford, Nova Scotia. The Company lists on the OTC Markets’ OTCQB.
Elcora Advanced Materials is targeting high-end graphite applications (Li-ion batteries, graphene production & coating). It acquired the full operational control and a 40 percent equity interest in Sakura Graphite (PVT) Limited, operators of the Ragedara mine in Sri Lanka. Sri Lanka graphite is very high quality with many unique properties. This graphite is suitable for use in numerous high-end graphite applications.
Elcora has secured high-grade graphite and graphene precursor graphite from its interest in the operation of the Ragedara mine in Sri Lanka. This mine is already in production. Currently, the mine yields about 500 tonnes each year.
The Company developed its own unique graphite refining process. The process does not require the use of acids or alkaline systems. Environmentally friendly, the process yields higher quality graphite that has not been oxidized and will withstand high temperatures.
Elcora announced in April 2017 that it is building a state-of-the-art Lithium Ion (Li-ion) battery research and development laboratory in Halifax, Nova Scotia. The lab will concentrate on quality control and developing the Company’s graphite anode powder for Li-ion batteries.
Graphite powder will be routinely tested employing industry standard cells. This is to ensure the coulombic efficiency, reversible capacity, first-cycle loss and rate capabilities of the product are within Elcora’s specifications.
Recently, Elcora Advanced Materials announced that it is working with a number of battery manufacturers in Asia that are testing the Company’s graphite anode powder. Elcora has so far sent more than14 kgs of its EL-I-C6 graphite anode powder to battery manufacturers to test its electrochemical performance.
The purpose of this testing is to demonstrate that the Company’s EL-I-C6 graphite anode powder meets Li-ion battery manufacturing standards. After more testing, Elcora Advanced Materials hopes to enter into negotiations for long-term supply agreements.
Moreover, in November, Elcora announced it signed a Memorandum of Understanding (MOU) agreement with Lockheed Martin Canada. This represents Lockheed Martin's first battery technology investment in Canada.
The strategic partnership supports the increasing energy demand for Lithium-Ion battery storage solutions applied to commercial, industrial, utility, and military applications. The MOU formally creates a working relationship and guidelines to support/identify opportunities within Lockheed Martin business units; including Lockheed’s energy division to help in maximizing and attaining sales goals.
Elcora Advanced Materials Corp. (ECORF), closed Monday's trading session at $0.04, up 50.3759%, on 500 volume with 1 trade. The average volume for the last 3 months is 14,022 and the stock's 52-week low/high is $0.0251/$0.097000002.
The QualityStocks Company Corner
- Willow Biosciences Inc. (CSE: WLLW)
- No Borders Inc. (OTC: NBDR)
- Xalles Holdings Inc. (OTC: XALL)
- Predictive Oncology (NASDAQ: POAI)
- Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI)
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF)
- SRAX Inc. (NASDAQ: SRAX)
- Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)
- Sigma Labs Inc. (NASDAQ: SGLB)
- The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
- MCTC Holdings Inc. (OTC: MCTC)
- ChineseInvestors.com (CIIX)
- Marijuana Company of America (OTCQB: MCOA)
- SinglePoint, Inc. (SING)
Willow Biosciences Inc. (CSE: WLLW)
Willow Biosciences Inc. (CSE: WLLW; OTCQB: CANSF) announces that it has received conditional approval from the Toronto Stock Exchange (the "TSX") to list its common shares (the "Common Shares") on the TSX. Final approval of the listing is subject to the Company meeting certain customary conditions required by the TSX. Willow will issue a statement once the TSX confirms the date when trading of the Common Shares will commence on the TSX.
Willow Biosciences Inc. (CSE: WLLW) is a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (“APIs”) and intermediates. The company’s cannabidiol (“CBD”) yeast-based biosynthesis program produces a high yield, ultrapure, low-cost and scalable manufacturing solution for pharmaceutical, food, beverage and personal care consumers of CBD.
The company is headquartered in Calgary, Alberta, Canada.
Willow’s proprietary yeast-based lab strains produce CBD, tetrahydrocannabinol (“THC”), and cannabigerol (“CBG”), as well as certain minor and novel cannabinoids.
The company’s expertise in the esoteric field of biosynthesis and in delivering commercial fermentation pathways for the production of pharmaceutical-grade compounds grew from its origins in opiate research. Willow recently delivered a de novo biosynthesis pathway in yeast for thebaine, a key precursor API used as a feedstock in the manufacture of semi-synthetic opiates such as naloxone (used to reverse opioid overdose) and several common analgesics. Led by Chief Scientific Officer Dr. Peter Facchini, Willow’s research team discovered and patented numerous previously unknown genes coding for core catalytic pathway enzymes, as well as a number of additional non-pathway, yet commercially-essential, accessory genes.
Utilizing this proven synthetic biology platform, Willow’s research team has already begun producing cannabinoids at lab scale, using yeast as the host cell “factory.” This biosynthetic fermentation-based process is capable of producing pharmaceutical grade CBD in 10 days – far less time than traditional plant-based extraction methods.
Willow anticipates its technology can be scaled to produce hundreds of kilograms per batch of cannabinoid API at less than $1,000 per kilogram, thus costing approximately 60% less than current chemical synthesis methods and 90% less than conventional plant-based extraction methods.
Willow and Noramco Inc., the world’s largest producer of high-quality synthetic cannabinoid APIs and other controlled substance APIs for the pharmaceutical and healthcare industry, have an exclusive, worldwide Joint Development Agreement (“JDA”) to design a yeast-based biosynthesis platform for the production and distribution of a highly pure CBD isolate.
The mutually exclusive agreement calls for Willow to be responsible for optimizing yeast strains in a biosynthetic process to generate ultrapure CBD at high yield and substantially lower cost compared to current methods. Noramco will leverage its decades of experience in producing and delivering CBD and pharmaceutical APIs by being responsible for the scale-up, regulatory submission, marketing and distribution of products manufactured under the JDA.
Each company will invest comparable funds, will retain the intellectual property associated with their respective scopes of work and share equally in gross profits from sales of products manufactured under the JDA.
The agreement with Noramco (http://nnw.fm/Mz1vW) addresses the increasing demand for CBD-based APIs and other CBD-infused products by pharmaceutical, nutraceutical, consumer packaged goods, beverages and other industry sectors.
The U.S. market potential of cannabinoids is significant, with industry analysts projecting $50 billion in cannabinoid-based pharmaceutical sales and $16 billion in CBD consumer goods retail sales by 2025. As of June 2019, 34 U.S. states and the District of Columbia, Guam, Puerto Rico and U.S. Virgin Islands have legalized cannabis for medical use. Another 13 states and territories have approved recreational cannabis for adult use while other states are considering similar measures.
The cannabinoid API market continues to evolve with CBD and other cannabinoid-based treatment options currently in clinical trials for indications such as post-traumatic stress syndrome, epilepsy, Parkinson’s disease, chronic pain, schizophrenia, cancer treatments and other challenging unmet medical conditions.
Willow is fully funded after raising $29 million via private placement and $8 million in exercised warrants by Tuatara Capital Fund II, L.P. Proceeds of the funding will be used to enhance the existing laboratory space in Calgary and Vancouver, Canada, and in San Francisco, California. The company anticipates exiting 2020 with $15.8 million in cash.
President and CEO Trevor Peters is an experienced executive who co-founded four startup companies in the past 15 years. He has raised over $1 billion in equity and debt financings at various stages of corporate development and has been integral to successful transactions totaling over $4 billion on sale. Mr. Peters previously was chief financial officer at Caracal Energy Inc., which sold to Glencore plc in 2014 for $1.8 billion.
Chief Financial Officer Travis Doupe has over 18 years of experience in financial leadership roles, principally in the international oil and gas industry, where he provided corporate strategic direction while overseeing all aspects of financial operations. Mr. Doupe is the treasurer and a member of the board of directors of the Canada Council for the Americas – Alberta and holds a CA-CPA designation and earned a bachelor’s degree in management from the University of Calgary.
Dr. Peter Facchini, Chief Scientific Officer, has been professor of plant biochemistry in the Department of Biological Sciences at the University of Calgary since 1995. He is recognized internationally as a leader in plant specialized metabolite biosynthesis. Dr. Facchini is the Canada Research Chair in Plant Metabolic Processes Biotechnology and has published more than 150 research papers and scholarly articles. Dr. Facchini received a PhD from the University of Toronto and conducted postdoctoral research at the University of Kentucky and Université de Montréal.
Dr. Joseph Tucker, Executive Chairman of the Board of Directors, holds more than 20 issued or pending patents and is a member of the Board of Directors of BioAlberta. He has extensive senior leadership experience in multiple public and private biotech companies. Dr. Tucker received a PhD in biochemistry and molecular biology from the University of Calgary.
Willow Biosciences Inc. (CSE: WLLW), closed Monday's trading session at $0.66, up 1.54%, on 19,650 volume with 28 trades. The average volume for the last 3 months is 84,156 and the stock's 52-week low/high is $0.529999971/$5.25.
- Willow Biosciences Receives Conditional Approval to List on the Toronto Stock Exchange
- Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) Posts Q3 2019 Financial Results, Operations Update
- Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) Eyes Opportunity to Provide Biosynthetic Cannabinoids in Market with Explosive Potential
No Borders Inc. (OTC: NBDR)
No Borders (OTC: NBDR) today announced it has received “qualification” of its Reg A offering with the SEC to raise up to $3 million. According to the update, No Borders received only a single comment back from the SEC during the Reg A review process and has subsequently filed state registrations in Colorado, New York and Florida. To view the full press release, visit http://cnw.fm/iWMC5 and http://cnw.fm/p1LD1
No Borders Inc. (OTCQB: NBDR) specializes in the acquisition, creation and scaling of commercial products by utilizing cutting-edge technologies designed to reduce costs while increasing revenues and shareholder value. With active subsidiaries in healthcare, education, cannabidiol (CBD), finance and technology, No Borders is uniquely positioned to use its expertise to improve margins and add business lines within target verticals. No Borders is headquartered in Arizona with remote work resources in the U.S., South America, Asia and Europe.
Different by Design
Deeply experienced at actionable data compilation, analysis and utilization, No Borders believes that data utilization in a Web 3 ecosystem of predictive analytics, blockchains, consensus algorithms, IoT and 5G are vital keys to the future of disrupting global business.
The company leverages its technological talent and visionary approach alongside best-in-class branding, messaging and product teams to simultaneously deploy multiple vertical product offerings at the same time.
With resources around the world, No Borders operates as a 100% remote work, lean operating organization with a founding ideological focus on “Lifestyle by Design.” No Borders’ teams are built by allowing people to work when they want and from where they want as long as deliverables and results are achieved. This structure allows for strategic talent acquisition without the need for relocation or commuting; lowered operating and fixed costs; as well as improved morale and substantially increased staff productivity.
- No Borders Dental Resources Inc. provides equipment and supplies to medical and dental professionals across the U.S. through the trade name, MediDent Supplies. MediDent has a strategic focus on expanding product portfolios and optimizing lifetime customer value while minimizing customer acquisition cost in the medical, dental and veterinary spaces.
- No Borders Naturals is a purveyor of health and wellness products for active consumers and their pets. No Borders Naturals aims to be an industry leader in alternative wellness product offerings and is currently expanding its digital offering with impactful product up-sell opportunities such as a series of “Buy Two-Get One” on products on its 1000mg CBD tincture, collagen and retinol beauty cream.
- No Borders Labs Inc. provides leading-edge tech tools to the No Borders family of companies along with building, testing and deploying technology solutions and products to the market while also offering consulting, architecture and software development services to external businesses looking to update their technology infrastructure for greater efficiency, security and transparency.
- No Borders Funding Inc. provides internal capital and strategic funding options for the family of No Borders companies while actively engaging and networking to find, acquire, structure and deploy unique financial products, solutions and systems with traditional, distributed ledger and blockchain technologies.
- No Borders Education Inc. provides internal staff training and strategic education tools for the No Borders family of companies while pursuing external revenue generating educational opportunities within the verticals for which No Borders deploys products, services or technologies.
No Borders CEO Joseph Snyder is a serial entrepreneur whose experiences in real estate investment, financial services and digital strategy over the last 15 years provide a strong, grounded foundation for the structure and ideas outlined in the company’s strategic plan. He brings a unique set of long-term business experiences that provide No Borders with a clear “mile-high” view of the intricately linked systems and challenges associated with growing and scaling our vision.
COO Cynthia Tanabe, a licensed real estate agent/broker since 2004, has successfully built a highly respected investor and bank-focused real estate and property management firm in Arizona with tens of millions of dollars of properties owned and sold.
CTO Chris Brown has 14 years of experience in the IT industry ranging from full stack programming, hardware support, engineering and maintenance, to enterprise-level information system analysis, design, development and implementation. From his background in Air Force intelligence to earning dual B.S. degrees in computational mathematics and biochemistry from Arizona State University, Brown has been engrossed with technologies such as artificial intelligence, machine learning, and decentralized blockchain ledger systems and their connections with real world business applications.
Management is backed by an advisory board with a diverse range of expertise blockchain, brand development, specialty retail, branded consumer products, technology, marketing and other specialties pertinent to No Borders’ growth strategy.
No Borders Inc. (NBDR), closed Monday's trading session at $0.0179, up 19.3333%, on 10,000 volume with 1 trade. The average volume for the last 3 months is 79,470 and the stock's 52-week low/high is $0.007699999/$0.048799999.
- No Borders Inc. (NBDR) Announces $3M Reg A Offering Qualification and Subsidiary’s First Publicly-Accessible Blockchain Product, CBD Lab Chain
- No Borders Inc. (NBDR) CEO Presents CBD LabChain Platform at Blockchain Expo 2019
- Is Smokable Hemp the Next Big Thing in Kentucky?
Xalles Holdings Inc. (OTC: XALL)
The prediction by some traders that cryptocurrencies have entered a bearish market despite a rapid upward move last month (http://ccw.fm/gJaU8) showcases the ongoing volatility of altcoin backers. While divergent financial strategies drive some forward-thinking investors to prefer fiat-partnered digital trading options, the currency independence of vehicles such as Bitcoin remain popular with their enthusiasts amid a number of international events highlighting the coins’ potential and pointing to the stability of the coins’ early adopters (http://ccw.fm/Wpl5t). Xalles Holdings Inc. (OTC: XALL) is a fintech holding company dedicated to offering a Cryptocurrency Trading Engine through a revenue-sharing agreement between one of its subsidiaries and automated cryptocurrency trader All The Numbers Trading Company, LLC (d/b/a ATN Trading).
Xalles Holdings Inc. (OTC: XALL) is a fintech holding company leveraging blockchain and other technologies for e-commerce, payments, financial reconciliation, and payment auditing solutions. The company actively seeks acquisition targets with strong management teams and business models, large total attainable markets, and lucrative exit opportunities in which to invest and accelerate growth.
The common element to all acquired entities and projects is a business model that involves setting up a payment or financial transaction “toll gate,” thereby creating a recurring revenue stream.
Xalles’ business plan focuses on consumer, business and government-oriented payment and financial reconciliation transactions. Combining the blockchain decentralized financial ledger platform with the company’s existing X2X transaction reconciliation system design, Xalles is building technology that supports payment audits, exchanges, and new business models and opportunities worldwide. Xalles will launch new services card and mobile payment and rewards systems, and will expand the technology offerings for referral marketing and e-commerce engines.
All current subsidiaries are wholly owned
- Xalles Holdings
Raise capital for fintech accelerator program acquisitions, provide management, administrative, finance and marketing support to all subsidiary companies
- Xalles Capital
Management support of investment consortiums, direct investment into funds or projects, and management of investments
- Xalles Limited
Design and market new X2X solutions; acquire U.S Government transportation post-payment audit business through GSA schedule and expand to non-transportation payment auditing
- Xalles Technology
Technical development of the X2X blockchain systems
- Xalles Financial Services
Consumer and small business financial service offerings
- Co-Owners Rewards
Stock-based rewards system for payments cards and financial services
- Amazing Living Enterprises
Affiliate program and e-commerce platform for enhancing financial lives
- Global Savings Network
Not-for-profit fundraising system with consumer discounts at local merchants
Xalles provides payment and financial transaction management solutions through the company’s proprietary blockchain-based X2X technology. The X2X solution includes the Investment and Financing System (IFS), which supports complex investment structures, assists international investment consortia, and provides links to Xalles’ Financial Transaction Reconciliation (FTR) solution. FTR supports complex financial ecosystems, making it easier for parties to exchange products, services, grants and government incentives, and assists “Exchange Managers” with liquidity and auditability. X2X also supports the Xalles pre- and post-payment auditing services.
Advancements in 2019
- Co-Owners Rewards subsidiary is working to launch a general purpose reloadable prepaid payment card with a stock rewards program.
- Previously announced LYC Mortgage acquisition will create a structure that will dramatically increase revenues in 2020 with new mortgage business portfolios.
- Xalles Financial Services expects to launch the Cryptocurrency Trading Engine and acquire multiple cryptocurrency asset portfolios to drive increases in value through the trading engine.
“The structure and growth plan for the company contains a balance of diversity and synergy so that we can effectively use limited resources to obtain the best results. We will see the culmination of the fundraising efforts, acquisitions and organic growth in the second half of 2019 put us on the path to tremendous growth in 2020.”
– Xalles CEO Thomas Nash (http://nnw.fm/rU6iT)
Xalles Holdings Inc. (OTC: XALL), closed Monday's trading session at $0.00235, up 4.4444%, on 24,666 volume with 2 trades. The average volume for the last 3 months is 79,470 and the stock's 52-week low/high is $0.0013/$0.021029999.
- Xalles Holdings Inc. (XALL) Maintains Nimble Fintech Profile Amid Crypto Volatility
- Xalles Holdings Inc. (XALL) Offering Solutions in E-Commerce, Payments, Financial Reconciliation Sectors
- Fintech Holding Company Xalles Holdings Inc. (XALL) Answers Crypto Business Needs as Coin Markets Gather New Strength
Predictive Oncology (NASDAQ: POAI)
Predictive Oncology (NASDAQ: POAI), focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced its recent receipt of notification (the “Notification Letter on Compliance”) from the Listing Qualifications Department of the Nasdaq Stock Market Inc. (the “Nasdaq”) that indicates Predictive Oncology has regained compliance with the minimum bid price requirement set forth in Rule 5550(a)(2) of the Nasdaq Listing Rules (the “Minimum Bid Price Requirement”). To view the full press release, visit http://nnw.fm/iqcW8.
Predictive Oncology (POAI) is a knowledge-driven precision medicine company focused on applying data and artificial intelligence (AI) to personalized medicine and drug discovery. The company applies its smart tumor profiling and AI platform to extensive genomic and biomarker patient data sets to build predictive models of tumor drug response to improve clinical outcomes for the cancer patients of today and tomorrow. The company has several tools that support its mission of bringing precision medicine to the treatment of cancer.
Through its subsidiaries, Predictive Oncology’s portfolio of assets includes the following:
- A database of clinically validated historical and outcome data from patient tumors
- An in-house Clinical Laboratory Improvement Amendments (CLIA)-certified lab
- A “smart” patient-derived tumor profiling platform
- An in-house bioinformatics artificial intelligence (AI) platform
- A new computerized approach growing tumors in the lab to rapidly develop patient specific treatment options
- An FDA-approved fluid collection and disposal system
Using these resources, and in collaboration with key players in the pharmaceutical, diagnostic and biotech industries Predictive Oncology is working to determine the best pathways for more individualized and effective cancer treatment.
Predictive Oncology leverages the synergies of its three wholly owned subsidiaries to bring precision medicine to the diagnosis of cancer.
Helomics applies artificial intelligence to its rich data gathered from the company’s trove of more than 150,000 tumors to personalize cancer therapies for patients as well as drive the development of new targeted therapies in collaborations with pharmaceutical companies. This database, the largest of its kind in the world, is comprised of ovarian, head and neck, colon and pancreas tumors. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy.
In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™ patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary platform (D-CHIP) to provide a tailored solution to its clients’ specific needs.
TumorGenesis is developing a new, rapid approach to growing tumors in the laboratory without the use of rats or mice, allowing for the identification of biomarkers indicative of cancer. This methodology “fools” the tumor into thinking it is still in the body. As a result, the tumor reacts as it naturally would, thereby increasing the accuracy of the biomarker. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and helps categorize an individual patient’s heterogeneous tumor samples to enable development of patient-specific treatment options.
Skyline Medical’s patented, FDA-cleared STREAMWAY® System is the first true, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. The STREAMWAY system is changing the way healthcare facilities collect and dispose of potentially infectious waste fluid by connecting directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids.
The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. The STREAMWAY eliminates canisters, carts and evacuated bottles, which reduces overhead costs and minimizes environmental impact by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United Sates.
Skyline has achieved sales in five of the seven continents through both direct sales and distributor partners.
Precision medicine has become the holy grail of cancer therapeutics. Data driven predictive models of tumors and their responses are critical in both new drug development and individualized patient treatment. The race has begun to model various tumors, which takes 5 to 7 years of clinical evaluation to establish historical and outcome data.
Predictive Oncology enjoys significant competitive advantage. The company already has a vast historical collection of tumors and related data, plus the ability to obtain existing associated outcome data. While others wait for outcome data, Predictive Oncology is in a unique and powerful position, working to deliver the promise of precision medicine to reality. Predictive Oncology already has the clinical data, including how a tumor responded to certain drugs, an in-house bioinformatics AI platform, and only needs to do the tumor sequencing. The significance is underscored by the collaboration with UPMC Magee-Women’s Hospital, designed to reveal which mutations responded to which drug then develop powerful predictive models for future testing and treatment.
Dr. Carl Schwartz was appointed to Skyline Medical’s board of directors in March 2015 and became interim president and CEO in May 2016. Dr. Schwartz became CEO of Plastics Research Corporation in 1988, leading the company to become the largest manufacturer of structural foam molding products in the U.S. with more than $60 million in revenues and 300 employees by the time he retired in 2001. He holds a bachelor’s degree and DDS degree from the University of Detroit.
CFO Bob Myers has over 30 years of experience in multiple industries focusing on medical device service and manufacturing. He has spent much of his career as a CFO and controller. Myers holds an MBA in Finance from Adelphi University and a BBA in public accounting from Hofstra University.
Gerald Vardzel, President of Helomics, has over 25 years of healthcare executive management experience developing and implementing commercialization strategies and models for technology launches. His Go-To-Market expertise includes equity financing, strategic planning, market intelligence, M&A, and new market development in both start-up and established settings including fortune 500 market leaders. He has developed innovative solutions for both CLIA and FDA regulatory paths defining the delivery chains from discovery to clinical acceptance. Mr. Vardzel also has significant experience designing and implementing sales and marketing programs tailored not only to expand market share, but to empirically assess client satisfaction, strengthen business processes, and maximize profitability. Mr. Vardzel was previously Vice President of Corporate Development and Strategic Initiatives at Global Specimen Solutions. Furthermore, as an executive affiliate to the healthcare industry, he routinely consults for several small-to-mid sized private equity firms advising on, in part, the feasibility of acquisition targets. Mr. Vardzel graduated from the University of Pittsburgh.
Dr. Mark Collins, Chief Information Officer of Helomics, has held multiple executive roles in a variety of discovery, informatics and bioinformatics functions within global pharma, and founded three startup software companies in the machine learning and drug discovery space. In 2001, Dr. Collins worked for Cellomics (now part of Thermo Fisher Scientific), where he played a pivotal role in establishing the High-Content Cell Analysis market, building and commercializing several key informatics and bioinformatics products. After leaving Thermo Fisher, Dr. Collins developed and commercialized informatics solutions for clinical and translational research, specifically in the specimen tracking, omics data management and NGS analysis space, through key roles at BioFortis, Global Specimens Solutions and Genedata. Dr. Collins received his undergraduate degree in Applied Science from the University of Wolverhampton, UK and his Ph.D. in Microbiology from the University of Surrey, UK.
Predictive Oncology (POAI), closed Monday's trading session at $3.28, off by 5.0211%, on 37,775 volume with 143 trades. The average volume for the last 3 months is 17,796 and the stock's 52-week low/high is $3.19600009/$8.50.
- Predictive Oncology Inc. (NASDAQ: POAI) Regains Compliance with Nasdaq’s Minimum Bid Price Requirement
- Predictive Oncology Inc. (NASDAQ: POAI) Secures $15 Million Equity Line
- Predictive Oncology Inc. (NASDAQ: POAI) CEO Discusses Corporate, Scientific Milestones in NetworkNewsAudio Interview
Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI)
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc., a leading licensed producer of cannabis, today announced its results for the fourth quarter and fiscal year ended August 31, 2019 (“Q4” or “Q4 2019”). Among the highlights, Organigram reported a 547% growth in 2019 net revenue to $80.4 million from $12.4 million in 2018, and a 575% increase in 2019 gross margin, before fair value changes to biological assets and inventory, to $37.9 million or 47% of net revenue from $5.6 million or 45% of net revenue in 2018. To view the full press release, visit http://cnw.fm/GS2eh. Also today, the company was featured in the 420 with CNW by CannabisNewsWire. This week, former Colorado public officials Stanley Garnett and Doug Friednash, who were opposed to marijuana legalization, shared their opinions with Minnesota legislators about the things to consider if cannabis is to be legalized.
Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) is the parent company of Organigram Inc., a leading Canadian licensed producer (“LP”) of high-quality cannabis and extract-based products. Founded in 2013, Organigram is focused on producing high quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to expand the Company’s global footprint.
The Company has distribution arrangements in all 10 provinces1. Organigram delivers industry-leading yields and maximizes quality cannabis production at the lowest cultivation cost per gram among publicly reporting Canadian LPs.
In Q2 2019, the Company reported record net revenue of C$26.9 million, cash cost of cultivation of C$0.65 per gram, industry leading gross margin of C$16 million or 60% and adjusted EBITDA of C$13.3 million or margin of 49%, positive for the third consecutive quarter.
Significant Expansion Plans with Streamlined Licensing Process
Located in Moncton, New Brunswick, Organigram’s production facility and research & development program includes a state of the art, indoor 3-tier cultivation system which maximizes facility square footage. Its Phase 4 expansion project is expected to be completed by the end of 2019 for increased target production capacity of 113,000 kg/year (249,000 lbs)2. As the Company expands its cultivation and processing capacities, Organigram is able to file amendments to the existing facility and each new production area is largely a replica of previously licensed areas, which results in a relatively streamlined and predictable licensing process with Health Canada.
In addition to increased production capacity from Phase 4, Organigram’s Phase 5 expansion includes plans for additional extraction capacity and its own edibles facility. Construction is expected to be substantially completed in October 2019.
The Company’s indoor facility allows for control of all critical facets of the lighting and environmental elements to drive maximum quality and yield in the plants. The Company’s in-house proprietary information technology system, called OrganiGrow, tracks grow cycles, environmental conditions and other factors to optimize cultivation.
Numerous design and automation improvements include automated potting, pre-roll and packaging machines, and larger propagation rooms with advanced environmental systems.
Well Positioned for Canada’s Legalization of Edibles and Other Derivatives Products
Through its facility expansions, partnerships and research and development, the Company is well-positioned to capture further growth from the legalization of edibles and derivative products expected in October 2019. Its initial product focus is on vaporizable products and edibles.
Organigram’s development of a shelf-stable, thermally stable, water-soluble and tasteless cannabinoid nano-emulsion formulation may provide for an initial onset of effect within 10 to 15 minutes in a beverage. Non-cannabis formulations with a similar molecule size are water-soluble in humans (i.e., absorbed through the bloodstream rather than requiring first-pass liver metabolism, which results in longer onset and duration uncertainty). The Company expects to receive research and development licensing in the near term, at which point testing will be conducted to confirm the onset and duration.
Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado for the development of commercial scale extraction and derivative product development in Canada. Organigram’s partnership with Canada’s Smartest Kitchen, a leader in food product development, will expand the Company’s edibles R&D program.
The Company recently announced a C$15 million investment commitment in a high-speed, high-capacity, fully automated production line with a capacity of 4 million kilograms of exceptional chocolate cannabis edibles per year.
Organigram also has a multiyear extraction contract with Valens GroWorks Corp. to produce extract concentrate for oils and other derivative products.
Through its partnership with Hyasynth Biologicals Inc., a biotech company and leader in the field of cannabinoid science and biosynthesis, Organigram has invested in a potentially disruptive technology that uses patented yeast strains and enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation. Organigram views this investment as providing early access to what it expects to be the future of cannabinoid production – cost-effectiveness, purity and scalability.
Organigram believes there will be increasing demand for CBD in Canada and beyond. As such, the Company has invested in Alpha-Cannabis Germany (ACG) and expects to provide ACG with flower for conversion into extracts. ACG is a medical cannabis provider serving the largest legalized medical market in Europe. The Company anticipates entering into an agreement with ACB to purchase pure synthetic CBD isolate in the future.
Organigram is also invested in Eviana Health Corp. (CSE: EHC), a Serbian-based company with hemp farming and processing assets.
Experienced Executive Team
- CEO Gregory Engel has 30 years of national and international experience in pharmaceuticals, biotechnology, cannabis, and consumer packaged goods (CPG), and most recently served as CEO of Tilray Inc. where he was instrumental in the company becoming the first Canadian exporter of medical cannabis, as well as establishing several trailblazing industry standards
- Jeff Purcell, Senior Vice President of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods
- Tim Emberg, Senior Vice President of Sales and Commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and CPG industries
- Paolo DeLuca, Chief Financial Officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities
- Ray Gracewood, Senior Vice President, Marketing & Communications, has 15 years of experience in the marketing space and was senior Director of Dales and Marketing for Moosehead Breweries Ltd.
This profile contains certain non-IFRS performance measures including cash and all-in cost of cultivation per gram, net revenue, adjusted EBITDA, and adjusted gross margin which are not calculated in accordance with IFRS and may not be comparable to similar data presented by other companies. Please see the company’s Q2 2019 MD&A.
1 Subject to final regulatory approval from Quebec
2 Several factors can cause actual capacity and costs to differ from estimates. See “Risks and Uncertainties” in the Company’s Q2 2019 MD&A and “Risk Factors” in the latest Annual Information Form.
Organigram Holdings Inc. (NASDAQ: OGI), closed Monday's trading session at $2.53, off by 4.1667%, on 4,421,341 volume with 12,200 trades. The average volume for the last 3 months is 2,100,992 and the stock's 52-week low/high is $2.00/$8.43999958.
- Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) Announces Q4 and 2019 Fiscal Year Results
- 420 with CNW – Minnesota Marijuana Legalization Advocates Take Lessons from Colorado
- Ohio Farmers Fear Draft Hemp Rules Could Lock Them Out
Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)
Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) today announced plans to release its financial results for the third quarter ended September 30, 2019 after market close on Friday, November 29, 2019. In addition, the company will host a conference call and webcast at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific Time on Monday, December 2, 2019, to discuss its results and recent corporate highlights. To view the full press release, visit http://cnw.fm/q5a7P. Also today, the company was highlighted in a publication from CBDWire, examining how cannabidiol (CBD), the cannabis extract that has been referred to as a ‘miracle drug’ by some has been all the rage over the past few years. Said to be effective against a variety of medical conditions, the compound has been subject to great interest.
Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.
First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.
PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.
Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.
During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:
- Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
- Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
- Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
- Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
- Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
- Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.
“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”
The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.
Plus Products Inc. (PLPRF), closed Monday's trading session at $1.82, off by 1.0224%, on 29,126 volume with 65 trades. The average volume for the last 3 months is 43,683 and the stock's 52-week low/high is $1.08749997/$6.00810003.
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Announces Date for Scheduled Release of Q3 2019 Results, Conference Call and Webcast
- Florida Poll Reveals Overwhelming Support for Cannabidiol Research
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Utilizes Multichannel Marketing Strategy to Increase National Profile
SRAX Inc. (NASDAQ: SRAX)
SRAX Inc. (NASDAQ: SRAX) is a digital marketing and data management technology company. Through SRAX’s BIGtoken platform, consumers have the opportunity to both own and monetize their data.
SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.
Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.
SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.
- SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
- SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
- SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
- SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
- SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
- SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.
BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.
The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.
Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.
Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.
SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.
BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.
The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.
SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.
BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.
Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.
Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.
SRAX Inc. (NASDAQ: SRAX), closed Monday's trading session at $1.29, off by 7.1942%, on 73,495 volume with 287 trades. The average volume for the last 3 months is 99,939 and the stock's 52-week low/high is $1.28999996/$5.8499999.
- SRAX Inc. (NASDAQ: SRAX) Reports Promising Q3 Results, Positions Itself for Global Adoption
- SRAX Inc.’s (NASDAQ: SRAX) BIGtoken App Makes Owning, Monetizing Personal Data Possible
- SRAX Reports Q3 2019 Vertical Sales Increase 17% Year-over-Year and Net Income of $1.4 Million
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) today reported its results for the thirteen-week period ended September 28, 2019. Revenues for the period totaled $12.7M.
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.
In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.
Products under the Green Growth Brand umbrella include:
- CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
- Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
- Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
- Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
- The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
- XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.
Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.
Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.
Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.
Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.
CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.
CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.
Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.
Green Growth Brands Inc. (OTCQB: GGBXF), closed Monday's trading session at $0.8829, off by 4.3238%, on 207,404 volume with 220 trades. The average volume for the last 3 months is 240,929 and the stock's 52-week low/high is $0.739199995/$5.20499992.
- Green Growth Brands Significant Revenue Growth Driven by CBD Retail Expansion
- 420 with CNW – Superstar Drake Joins Cannabis Industry by Partnering with Canadian Pot Company
- 420 with CNW – Yale Teams Up With Weed Company to Study Effects of Cannabis on Stress
Sigma Labs Inc. (NASDAQ: SGLB)
Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the commercial 3D printing industry, today announced that it has been invited to present at the 12th Annual LD Micro Main Event. The event is slated to take place at the Luxe Sunset Boulevard Hotel in Los Angeles, California on December 10-12, 2019. To view the full press release, visit http://nnw.fm/PGg3N
Sigma Labs Inc. (SGLB) is the only provider of in-process quality-assurance software to the commercial 3D printing metal industry that enables operators of machines making 3D metal parts to offset emerging quality problems, sustain part quality, and avoid rejects. Sigma’s software is the singular solution that enables both real-time, in-process detection of quality control manufacturing irregularities for critical metal parts and then provides the operator the actionable information needed to adjust and mitigate the developing anomaly. Sigma Labs’ software represents a paradigm shift in the quality control process for the manufacture of 3D printed metal components. The nascent 3D metal printing industry is on the verge of radically altering the speed and technical complexity of manufactured parts. Further, it makes possible just-in-time availability of critical components – all at reduced cost, time, waste and weight. 3D printing, heralded as the fourth industrial revolution in manufacturing, will only truly surpass traditional techniques when the additive manufacturing industry moves from “post process” quality control to “in process” quality assurance.
For the industry to move from prototype manufacturing of critical components to economically viable commercial production, the 3D metal printing industry must find ways to dramatically increase production speed and quality yields, and to dramatically decrease the excessive cost of quality control. To achieve these prerequisites and move 3D metal printing into the mainstream, parts must be inspected and certified during the manufacturing process rather than after. Parts in the production process that are developing signs of quality control problems must be identified in real-time and alerts must be issued. The problem, along with the solution, must then be communicated to the machine operator to implement repairs.
Revolutionizing Additive Manufacturing
Sigma Labs, with its PrintRite3D® brand, has established a new benchmark in the development and commercialization of real-time computer aided inspection (“CAI”) solutions. Sigma Labs resolves the major roadblocks and costly quality control challenges that impede the 3D manufacture of precision metal parts. The company’s breakthrough computer-aided software product revolutionizes commercial additive manufacturing, enabling non-destructive quality assurance during production, uniquely allowing errors to be corrected in real-time.
Sigma Labs was founded in 2010 by a team of Los Alamos National Labs scientists and engineers to develop and commercially license advanced metallurgical products for the military ordinance, dental implants, and then for additive manufacturing (3D printing). After assessing 3D metal printing technology and the costly, inconsistent quality control issues, Sigma Labs concluded that the enormous potential of 3D metal printing could only scale up if in-process quality-assurance tools were developed to observe, manage and control the manufacturing complexities in such a manner that reliability and repeatability of very high precision quality metal parts could be achieved in the process. Sigma Labs’ patented and third-party validated software has achieved these objectives and now delivers the critical elements needed to unleash the promise of 3D metal printing.
Sigma Labs’ products and services are engineered, manufactured and qualified for use in the highly demanding and hyper precise production environments of the aerospace, defense, transportation, oil and gas, biomedical and other precision-dependent industries.
Additive metal manufacturing combines multiple processes and parts into one single 3D printed part. Due to variances in the additive manufacturing process, parts of consistent quality currently can’t be reliably produced in either large or small quantities without substantial postproduction inspection and rejection costs. Parts are inspected after production using CT scans and other means, so the manufacturer doesn’t know until the very end which of the finished parts meet design specifications. This means lost time, lost profits and inability to economically scale up production.
Sigma Labs solves this problem with its patented, in-process quality control technology that informs operators and engineers how to improve both the manufacturing process and quality by capturing meaningful data about inconsistencies in real-time. Sigma Labs is also partnering with OEMs, working toward the visionary introduction of revolutionary closed-loop control that will bypass the machine operator and automatically make in process corrections by reducing machine variations.
Sigma Labs’ next generation technology gives manufacturers the ability to make fast, virtual real-time adjustments so that each finished part is uniform and within critical specifications, thereby improving production quality, decreasing end-users’ risks and waste, and increasing profits and speed to market. Sigma Labs’ PrintRite3D® IPQA Software monitors and assesses the quality of each production part in the 3D additive manufacturing process – layer by layer, and in real-time. This has never been available until now.
Sigma Labs maintains a strong intellectual property portfolio consisting of trade secrets, process know-how and 34 patents either granted, pending or awaiting pre-publication around the globe. These patents encompass the fundamental technologies underlying Sigma Labs’ melt pool process control, data analytics, anomaly detection, signature identification, and future “closed-loop control” of 3D metal printing.
Providing advanced quality assurance software to the commercial 3D printing industry is currently a $1.4 billion addressable market expected to grow to $3.9 billion by 2023. Integrating Sigma Labs’ groundbreaking software helps arm the industry with a necessary catalyst to help enable and optimize the fourth industrial revolution in manufacturing.
Sigma Labs’ global client base includes 23 installations across 19 different users. Tier-1 OEM enterprises and end-users such as Siemens, Honeywell, Pratt & Whitney and others are currently evaluating PrintRite3D® for production lines.
John Rice, CEO and chairman of the board of directors, has extensive experience as a CEO, lead negotiator, turnaround expert, business financier and crisis management executive/consultant. Prior to becoming chair and CEO of Sigma Labs, he was the CEO of a successful turn-around of a Coca-Cola Bottling Company. Rice has led a variety of companies in diverse business sectors and worked on a host of products and technologies including design and manufacture of high-end jet engine test equipment for the U.S. Airforce, chaff dispensers for F16s, software for modeling naval exercises, software for controlling warehouse distribution systems, medical radioisotopes, cancer detection, and cybersecurity. He is an honor’s graduate of Harvard College.
Darren Beckett, CTO, has over 20 years of experience in the semiconductor industry, including Intel Corporation, where he held various technical and managerial positions. His expertise in process engineering for advanced manufacturing technology includes statistical process control for fabrication of semiconductor devices.
CFO Frank D. Orzechowski also serves as treasurer, principal accounting officer, principal financial officer and corporate secretary. He has more than 30 years of distinguished financial and operational experience. Orzechowski began his career at Coopers & Lybrand in 1982, received his CPA certification in 1984, and received his Bachelor of Science in Business Administration with a major in accounting from Georgetown University in 1982.
Ronald Fisher, vice president of business development, is leading the commercialization of PrintRite3D® 5.0. Fisher is a mechanical engineer with hands-on experience in quality, manufacturing and product development. He has distinguished himself as a lead sales and marketing officer as well as a chief operating officer most recently before joining Sigma in technology startup that grew from market entry to successful exit by merger-acquisition.
Sigma Labs Inc. (SGLB), closed Monday's trading session at $0.8625, off by 10.7143%, on 227,252 volume with 467 trades. The average volume for the last 3 months is 171,439 and the stock's 52-week low/high is $0.451099991/$2.46000003.
- Sigma Labs, Inc. (NASDAQ: SGLB) CEO to Present at the 12th Annual LD Micro Main Event
- Sigma Labs Highlighted in Evaluation of Disruptive Technologies in Lucrative Global Manufacturing Industry
- Sigma Labs Awarded PrintRite3D Upgrade Contract with Leading Industry Research Institute Fraunhofer IAPT
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium certified organic cannabis, today announced receipt of its inaugural purchase order from the BC Liquor Distribution Branch ("BCLDB"), further expanding its Canadian distribution footprint. The company also obtained a Health Canada license amendment, allowing it to launch cultivation operations at its flagship Valleyfield hybrid greenhouse. To view the full press release, visit http://cnw.fm/Dzr0S. Also today, the company was featured in a publication from CannabisNewsWire, examining how TGODF recently signed agreements for increased funding amounting to up to $103 million.
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).
Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.
TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.
Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.
Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.
The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.
The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.
TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.
Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.
Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.
TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.
To learn more about the company and how to invest, contact TGOD directly at email@example.com
The Green Organic Dutchman (OTC: TGODF), closed Monday's trading session at $0.6745, off by 6.3194%, on 2,029,237 volume with 846 trades. The average volume for the last 3 months is 1,281,007 and the stock's 52-week low/high is $0.469300001/$4.38000011.
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Expands Canadian Distribution, Initiates Cultivation at Valleyfield Hybrid Greenhouse
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Anticipates Increased Funding of up to $103 Million
- Mother Shares Story of Son’s Miraculous Cure After Taking CBD
MCTC Holdings Inc. (OTC: MCTC)
MCTC Holdings (OTC: MCTC), a science forward intellectual property focused company developing unique hemp infusion technologies, today announced a new class of hemp infusion technology designed to replace alcohol in many beverages. According to the update, the infusion will be marketed under MCTC’s Hemp You Can Feel(TM) brand name and adds to its growing portfolio of intellectual property. To view the full press release, visit http://cnw.fm/tJJ0t.
MCTC Holdings Inc. (OTC: MCTC) is an innovator in the field of cannabinoid nanoparticles and infusion technologies with several important cannabinoid patents filed and an active research and development program underway. The company was reorganized during June of 2019 and announced its intent to enter the cannabis sector and change its corporate identity to Cannabis Global Inc. The company is headquartered in Los Angeles, California.
With the hemp and cannabis industries rapidly expanding in terms of market size, acceptance and number of market participants, MCTC plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The company is actively pursuing R&D programs and productization of advanced cannabinoid delivery systems, based on solid polymeric nanoparticles and fibers. These technologies hold the promise to revolutionize the science of cannabinoid bio-enhancement for use in foods, beverages, consumer products and in transdermal applications. Because of nanoparticles’ ability to be quickly absorbed into the bloodstream, nanotechnology has been utilized in the food and drug industry for some time and has the potential for tremendous growth in the cannabis industry (http://nnw.fm/v6RQ6).
MCTC is at the cutting-edge of the cannabis industry’s trends with its emphasis on polymeric nanotechnology. This is not to be confused with the more basic oil-in-water nano-emulsions currently marketed to the food and beverage industry. The company’s polymer-based particles offer significant loading of active ingredients and unmatched flexibility and customization, allowing for myriad combinations of cannabinoids with unique performance characteristics. MCTC believes polymeric nanotechnology particles will be a critical technology area for the cannabinoid formulation marketplace.
The company continues to build its R&D program, specifically researching the development of improving methods to make cannabinoids available to living systems. Instrumental in the research program is the development of novel polymeric nanoparticles and nanofibers. These have the potential to elevate the potential of cannabinoid products in the following ways (http://nnw.fm/cK3Bl):
- Significantly improving bioavailability
- Allowing for ultra-high loading rates
- Enhancing customization of cannabinoid combinations
- Improved dosing precision
- Providing more control in release parameters
MCTC leadership understands the importance of developing intellectual property (IP) in the ever-evolving cannabis industry. A recent Forbes article described IP as “critical for creating true differentiation between companies and their product and service offerings” (http://nnw.fm/57Fjh). Recognizing the importance of IP, MCTC has been consistent in its application for patents to protect its innovative nanotechnology applications.
MCTC has now filed four patents on its cannabinoid delivery technology systems:
- The company first collaborated with Cannabis Nanosciences Inc. on technologies. This became the basis for its first patent filing on an innovative edible dissolvable film for cannabinoid ingestion.
- Its second patent filing for cannabinoid nanoparticles combined TPGS, a water-soluble form of vitamin E.
- Its third patent filing involved a unique 4th dimension, 3D printed cannabinoid delivery system for beverages.
- Its fourth patent, considered its most significant, broadly covers many aspects of nanoparticles and nano fibers comprising one or more cannabinoids disposed at least partially within a water-soluble medium.
MCTC collaborated with Marijuana Company Inc. (OTCQB: MCOA) subsidiary hempSmart Inc., under a hemp extract and CBD product supply agreement wherein hempSmart will utilize its extensive network of marketing partners to market MCTC’s powered drink mixes and other CBD edibles online. These products are designed for the dry beverage and edibles sector and will be supplied by MCTC. They incorporate the company’s patent-pending cannabinoid infusion technologies and will be trademarked as Hemp You Can Feel (TM) and Gummies You Can Feel (TM).
MCTC CEO and chairman Arman Tabatabaei boasts 15 years of management and operations experience and is considered an expert at data collection and analysis relative to resource management, risk forecasting, and profit and loss management. He has acted as a consultant with Cannabis Strategic Ventures (OTCQB: NUGS) and played an instrumental role in improving operations at Sugarmade Inc. (OTCQB: SGMD) relative to the company’s hydroponic growth supplies initiatives.
MCTC founder and director Robert Hymers also brings a seasoned perspective, having had significant experiences in the cannabis industry and as a financial executive and consultant. He is the managing partner of Pinnacle Tax Services in Los Angeles and was previously CFO and director of Marijuana Company of America Inc. (OTC: MCOA). He is currently a member of the Strategic Advisory Board at Massroots Inc. and acts as a consultant to both Cannabis Strategic Ventures Inc. and Sugarmade Inc. Hymers’ background in tax accounting, auditing, SEC reporting, mergers and acquisitions, and corporate finance has immense value in his current position at MCTC Holdings.
MCTC Holdings Inc. (MCTC), closed Monday's trading session at $0.545, off by 20.438%, on 116,388 volume with 41 trades. The average volume for the last 3 months is 11,277 and the stock's 52-week low/high is $0.075000002/$3.00.
- MCTC Holdings, Inc. (MCTC) Announces New Class of Hemp You Can Feel(TM) Infusion Technology as Replacement for Alcohol in Beverages
- Hemp Farmers Hopeful as International Auction Starts in Tennessee
- Coverage Initiated for MCTC Holdings Inc. via NetworkNewsWire
ChineseInvestors.com (OTCQB: CIIX), an established financial news and investment portal as well as a leading industrial hemp retailer for the Chinese-speaking community, today announced that its subsidiary CBD Biotech, Inc., an exempted company with limited liability incorporated in the Cayman Islands, was featured in a recent Wall Street Journal report. To view the full press release, visit http://cnw.fm/u54wM.
Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.
Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.
At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.
CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.
The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.
Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.
In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.
ChineseInvestors.com (CIIX), closed Monday's trading session at $0.2352, off by 5.92%, on 79,333 volume with 33 trades. The average volume for the last 3 months is 45,671 and the stock's 52-week low/high is $0.165000006/$0.654999971.
- ChineseInvestors.com Inc.’s (CIIX) CBD Biotech Featured in Wall Street Journal Report on Growing Cannabis Industry in China
- ChineseInvestors.com Inc. (CIIX) to Host Investor Conference Call This Afternoon
- ChineseInvestors.com Inc. (CIIX) CEO Describes Tremendous Opportunity in CBD-Cosmetics to China’s Market of 1.4 Billion Consumers
Marijuana Company of America Inc. (MCOA)
Marijuana Company of America (OTCQB: MCOA) was featured today in a publication from HempWireNews, examining ho, if hemp were a person, they’d be having the time of their life right now. For the past few years, the crop has been subject to a slew of legislation that released it from the shakes of prohibition. First, the 2018 Hemp Farming Act, part of the Farm Bill, classified cannabis with less than 0.3% THC (delta-9 tetrahydrocannabinol) as hemp.
Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.
The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.
The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.
The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.
Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.
Marijuana Company of America Inc. (MCOA), closed Monday's trading session at $0.1674, off by 2.3907%, on 406,991 volume with 146 trades. The average volume for the last 3 months is 331,134 and the stock's 52-week low/high is $0.023/$2.10599994.
- First US Hemp Tracking System Launched in DelawareFirst US Hemp Tracking System Launched in Delaware
- 420 with CNW – New Jersey Lawmakers Now Say Voters Will Have Final Say on Marijuana Legalization
- Company Teams Up With Florida State University to Study Painkilling Effects of CBD
SinglePoint, Inc. (SING)
SinglePoint Inc. (OTCQB: SING), a leading technology and acquisition company, has announced its financial results for third quarter 2019 (http://cnw.fm/9jzqI). Highlights include a revenue increase of 176% over the same period in 2018 and a gross profit increase of 30%. The revenues and gross profit are on an upward swing. This is the first time SING has done over $1 million in a quarter.
SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.
SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.
SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:
- A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
- A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
- A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
- Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
- Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
- Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.
SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.
Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.
SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.
SinglePoint, Inc. (SING), closed Monday's trading session at $0.01054, off by 3.8321%, on 2,792,494 volume with 84 trades. The average volume for the last 3 months is 2,741,079 and the stock's 52-week low/high is $0.009999999/$0.028799999.
- SinglePoint Inc. (SING) Reports Record Quarter, Projects Promising Future
- Company Teams Up With Florida State University to Study Painkilling Effects of CBD
- SinglePoint, Inc. (SING) Subsidiary Exceeds Revenue Growth Goals in Q3 2019
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- B2Digital Inc. (BTDG) Secures Fully Reporting Status with SEC
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Announces Entry into Second Phase Development of Immersive Educational Materials
- Cannabis Strategic Ventures, Inc. (OTCQB: NUGS) 420 with CNW – Vote to Legalize Marijuana Federally Planned in Congressional Committee
- Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Colorado Farmers Invent Novel Hemp Harvester
- ChineseInvestors.com (CIIX) to Host Investor Conference Call This Afternoon
- Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF) to Acquire 19.9% Equity Interest of Coastal Green, a BC-Based Cannabis Retailer
- City View Green (CSE: CVGR) (OTCQB: LRZZF) Announces Closing of First Tranche of Private Placement
- CloudCommerce (OTCQB: CLWD) Benefiting from Dramatic Transition to Digital Advertising
- Dama Financial - Enters Strategic Partnership with PayWana
- Endonovo Therapeutics (OTCQB: ENDV) Revenues Up 153% in Q3, SofPulse® Already Successfully in Use at Over 30 Medical Facilities Nationwide
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) to Present at Upcoming LD Micro Main Event
- Genprex, Inc. (NASDAQ: GNPX) Announces $1.26 Million Registered Direct Offering
- GP Solutions (GWPD) Announces Launch of “Prolific Soilless Growth Medium” and “Prolific Hydro” on Amazon
- Grapefruit Boulevard Investments Inc. (IGNG) CBD Helps Connecticut Chiropractor With Lyme Disease To Quit OTC Medications
- Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) 420 with CNW – Superstar Drake Joins Cannabis Industry by Partnering with Canadian Pot Company
- Green Hygienics Holdings Inc. (OTC: GRYN) Expands Management Team, Advisory Board to Lead Key Business Strategies
- Hemptown USA - Strategically Positioned to Become Largest North American Producer of CBD
- HTC Extraction Systems (TSX.V: HTC) to Acquire California-based Kase Farma Inc.
- InsuraGuest Inc. - Secures Contract to Offer Specialized Insurance Coverage for South Carolina Red Lion Location
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) 420 with CNW – Why Humidity Matters During Cannabis Cultivation
- Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) NY Activists Vow to Improve Stalled CBD and Hemp Bill
- LiveWire Ergogenics Inc. (OTC: LVVV) New Jersey Senate Passes Bill Urging Feds to Enact CBD Dosage Guidelines
- Marijuana Company of America Inc. (MCOA) 420 with CNW – New Jersey Lawmakers Now Say Voters Will Have Final Say on Marijuana Legalization
- MCTC Holdings Inc. (MCTC) Coverage Initiated via NetworkNewsWire
- MustGrow Biologics Corp (CSE: MGRO) Intends to Tackle New Fusarium Pathogen Threatening Worldwide Banana Supply
- Neutra Corp. (OTCQB: NTRR) Is Smokable Hemp the Next Big Thing in Kentucky?
- No Borders Inc. (OTC: NBDR) CEO Presents CBD LabChain Platform at Blockchain Expo 2019
- Nightfood, Inc. (OTCQB: NGTF) Secures Distribution Commitment from Additional Top-10 Supermarket Chain
- Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) Ohio Farmers Fear Draft Hemp Rules Could Lock Them Out
- ORHub Inc. (ORHB) Announces Successful Execution of a New Sales Contract
- OriginClear (OCLND) Driving Disruption of Trillion-Dollar Water-Treatment Industry
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Announces Successful Completion of Phase 1 Nickel/Cobalt Process Recovery Program
- Pacific Software, Inc. (PFSF) Collaborates with Império for Commercial Marketing and Promotion of BOAPIN.com Trade Portal
- Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) Announces Completion of Automation, Strategic Account Payment Structure With Valkor Oil and Gas and Appoints New Advisory Board Member
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Utilizes Multichannel Marketing Strategy to Increase National Profile
- Predictive Oncology Inc. (NASDAQ: POAI) Secures $15 Million Equity Line
- Pressure BioSciences Inc. (PBIO) PCT Platform Highlighted at IGCS Conference in Brazil
- Quest Patent Research Corp. (QPRC) Actively Harvesting IP Asset Portfolio
- Sharing Services Global Corporation (SHRG) Unique Selling Method Drives Sales
- Sigma Labs, Inc. (NASDAQ: SGLB) Highlighted in Evaluation of Disruptive Technologies in Lucrative Global Manufacturing Industry
- SinglePoint, Inc. (SING) Teams Up With Florida State University to Study Painkilling Effects of CBD
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Receives $950K Purchase Order from Top US Distributor
- Spectrum Global Solutions, Inc. (SGSI) Releases Q3 2019 Financial Results
- Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G) 420 with CNW – Clinical Trials of Cannabis as a Treatment for Pancreatic Cancer Expected
- SRAX Inc. (NASDAQ: SRAX) BIGtoken App Makes Owning, Monetizing Personal Data Possible
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) CEO to Participate in Two Upcoming Industry Conferences
- Sugarmade, Inc. (SGMD) Announces Strong Preliminary Calendar 2019 Performance that Exceeds Internal Forecasts
- The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Announces Appointment of Global CPG Executive John Griese as Chief Operating Officer
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Mother Shares Story of Son’s Miraculous Cure After Taking CBD
- Trxade Group Inc. (TRXD) Posts Continued Growth, Record Revenues in Third Quarter
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) Cantor sees 19% upside in J&J in premarket analyst action
- VPR Brands, LP (VPRB) How the National Hemp Rules Could Affect Idaho
- Willow Biosciences Inc. (CSE: WLLW) Posts Q3 2019 Financial Results, Operations Update
- Wonderfilm Media (TSX.V: WNDR) (OTCQB: WDRFF) Posts Q3 2019 Financial Results, Operations Update
- Xalles Holdings Inc. (XALL) Offering Solutions in E-Commerce, Payments, Financial Reconciliation Sectors
- Youngevity International, Inc. (NASDAQ: YGYI) President and CFO to Present at The Benchmark Company’s 8th Annual Discovery 1×1 Investor Conference
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.